J, D., L, Z., & X, Z. (2026). Rituximab in pediatric refractory nephrotic syndrome: A systematic review and meta-analysis evaluating therapeutic efficacy and adverse event profiles. Pediatric nephrology (Berlin, Germany), 41(6), 1611. https://doi.org/10.1007/s00467-025-07013-8
Chicago Style (17th ed.) CitationJ, Deng, Zhu L, and Zhu X. "Rituximab in Pediatric Refractory Nephrotic Syndrome: A Systematic Review and Meta-analysis Evaluating Therapeutic Efficacy and Adverse Event Profiles." Pediatric Nephrology (Berlin, Germany) 41, no. 6 (2026): 1611. https://doi.org/10.1007/s00467-025-07013-8.
MLA (9th ed.) CitationJ, Deng, et al. "Rituximab in Pediatric Refractory Nephrotic Syndrome: A Systematic Review and Meta-analysis Evaluating Therapeutic Efficacy and Adverse Event Profiles." Pediatric Nephrology (Berlin, Germany), vol. 41, no. 6, 2026, p. 1611, https://doi.org/10.1007/s00467-025-07013-8.